SCHEMBL19973511

SCHEMBL19973511

CCOC(=O)c1cccc2c1OCCC2=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.49
ALDH1A1 P00352 7/20 0.47
HSD17B10 Q99714 5/20 0.47
CYP1A2 P05177 2/20 0.44
MAPT P10636 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
USP2 O75604 1/20 0.44
CYP3A4 P08684 1/20 0.44
ALOX15 P16050 1/20 0.44
MAPK10 P53779 1/20 0.44
PTK2B Q14289 1/20 0.44
NCOA1 Q15788 1/20 0.44
NCOA3 Q9Y6Q9 1/20 0.44
PARP1 P09874 1/20 0.43
GAA P10253 1/20 0.42
KDM4E B2RXH2 4/20 0.42
HPGD P15428 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19973891 0.85 PARP1 (0.47) TSHRALDH1A1HSD17B10MAPTKMT2A
SCHEMBL27769402 0.80 PARP1 (0.50) ALDH1A1HSD17B10PARP1KDM4EHPGD
SCHEMBL11630902 0.79 ALDH1A1 (0.60) TSHRALDH1A1HSD17B10CYP1A2MAPT
SCHEMBL6836766 0.78 PARP1 (0.51) ALDH1A1HSD17B10MAPTALOX15PARP1
SCHEMBL5212249 0.77 CTNNB1 (0.54) TSHRALDH1A1HSD17B10GAAL3MBTL1
SCHEMBL8876227 0.77 PARP1 (0.50) ALDH1A1ALOX15PARP1MAOAMAOB
SCHEMBL7699846 0.76 TSHR (0.46) TSHRALDH1A1HSD17B10CYP1A2MAPT
SCHEMBL11632498 0.76 ALDH1A1 (0.53) TSHRALDH1A1HSD17B10CYP1A2MAPT
SCHEMBL30236695 0.76 ALDH1A1 (0.53) TSHRALDH1A1HSD17B10CYP1A2MAPT
SCHEMBL21189488 0.76 MAPT (0.38) TSHRALDH1A1HSD17B10CYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed
WO-2018052967-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS TSHR 3232/4885ALDH1A1 3241/4885HSD17B10 1740/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS TSHR 3232/4885ALDH1A1 3241/4885HSD17B10 1740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.